Calming and Sleeping in Serbia

June 2013 | 15 pages | ID: C823E44EA38EN
Euromonitor International Ltd

Abstracts

In 2002, the Serbian government decided to drastically decrease abusive use of Rx calming and sleeping products via better controls of sales and more rigorous criteria for obtaining doctor’s prescriptions. Since then, all Serbian consumers looking for calming or sleeping products without a doctor’s examination have had to accept OTC brands. However, at that moment the offer of such products remained poor while demand had started to rise. This represented an opportunity for producers. Some...

Euromonitor International's Calming and Sleeping in Serbia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2008-2012, allowing you to identify the sectors driving growth. Forecasts to 2017 illustrate how the market is set to change.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

• Get a detailed picture of the Calming and Sleeping market;
• Pinpoint growth sectors and identify factors driving change;
• Understand the competitive environment, the market’s major players and leading brands;
• Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts Globalwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

Contents

CALMING AND SLEEPING IN SERBIA
Euromonitor International
June 2013

LIST OF CONTENTS AND TABLES

Headlines
Trends
Switches
Competitive Landscape
Prospects
Category Data
  Table 1 Sales of Calming and Sleeping: Value 2007-2012
  Table 2 Sales of Calming and Sleeping: % Value Growth 2007-2012
  Table 3 Calming and Sleeping Company Shares 2008-2012
  Table 4 Calming and Sleeping Brand Shares 2009-2012
  Table 5 Forecast Sales of Calming and Sleeping: Value 2012-2017
  Table 6 Forecast Sales of Calming and Sleeping: % Value Growth 2012-2017
Executive Summary
Increase in Number of Modern Easy-to-use Products Over Review Period
Slowing Value Sales Growth in 2012
International Players Slowly Gain Sales Share From Domestic Companies
Halt in Expansion of Pharmacies
Crisis Will Continue To Choke Development
Key Trends and Developments
Prevention Before Healing
Aging Population
Increase of Self-medication
Market Indicators
  Table 7 Consumer Expenditure on Health Goods and Medical Services 2007-2012
  Table 8 Life Expectancy at Birth 2007-2012
Market Data
  Table 9 Sales of Consumer Health by Category: Value 2007-2012
  Table 10 Sales of Consumer Health by Category: % Value Growth 2007-2012
  Table 11 Consumer Health Company Shares 2008-2012
  Table 12 Consumer Health Brand Shares 2009-2012
  Table 13 Sales of Consumer Health by Distribution Format: % Analysis 2007-2012
  Table 14 Sales of Consumer Health by Category and Distribution Format: % Analysis 2012
  Table 15 Forecast Sales of Consumer Health by Category: Value 2012-2017
  Table 16 Forecast Sales of Consumer Health by Category: % Value Growth 2012-2017
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Switches
Sources
Summary 1 Research Sources